Covid-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already starting to tick up. Forecasts from the US Centers for Disease Control and ...

Jane Tuckerman has previously received funding from GlaxoSmithKline (investigator-led research). Funding has been directed to her research institution. There are no conflicts relevant to this article.

The vaccine for RSV is being expanded to pregnant women and older people, with the NHS beginning rollout this week. The NHS says the vaccines could prevent thousands of hospital admissions for ...

FRESNO, Calif. (KFSN) -- The RSV season could be just around the corner, according to doctors. The disease reaches its peak in the winter, and then tapers off in the spring. "RSV used to be ...

Nearly 5,000 people in Jersey are eligible for the new Respiratory Syncytial Virus (RSV) vaccine which is being rolled out on the island from today. RSV can cause lung infections including ...

The European Commission on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- the first time the bloc has authorised an mRNA shot against a disease other than ...

The Centers for Disease Control and Prevention recommends adults 75 and older and those 60 and older at risk of respiratory diseases get a shot to protect against respiratory syncytial virus ...

BEYFORTUS is the first and only long-acting monoclonal antibody approved for the prevention of RSV lower respiratory tract disease in newborns and infants born during or entering their first RSV ...

For the first time, the NHS will be vaccinating people against Respiratory Syncytial Virus (RSV), a common cause of coughs and colds that can lead to severe lung infections like pneumonia and ...